PANCREATIC CANCER NON-RESECTABLE
Clinical trials for PANCREATIC CANCER NON-RESECTABLE explained in plain language.
Never miss a new study
Get alerted when new PANCREATIC CANCER NON-RESECTABLE trials appear
Sign up with your email to follow new studies for PANCREATIC CANCER NON-RESECTABLE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cocktail aims to shrink untreatable pancreatic tumors
Disease control Not yet recruitingThis study tests a combination of three drugs (tunlametinib, chemotherapy, and cetuximab β) as a first treatment for people with advanced pancreatic cancer that cannot be removed by surgery. The goal is to see if the combo can shrink tumors and improve survival. About 28 adults w…
Matched conditions: PANCREATIC CANCER NON-RESECTABLE
Phase: PHASE4 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
Pancreatic cancer patients get targeted chemo via new catheter
Disease control Not yet recruitingThis early study tests a special catheter that delivers the chemotherapy drug Gemcitabine directly into or near pancreatic tumors. It includes 9 people with advanced pancreatic cancer that cannot be removed by surgery. Each person gets four treatments, two weeks apart, and is fol…
Matched conditions: PANCREATIC CANCER NON-RESECTABLE
Phase: PHASE1, PHASE2 • Sponsor: Smartwise Sweden AB • Aim: Disease control
Last updated May 11, 2026 20:41 UTC